<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-W0WOVSQZ</identifier><date>2010</date><creator>Anderluh, Marko</creator><relation>documents/doc/W/URN_NBN_SI_doc-W0WOVSQZ_001.htm</relation><relation>documents/doc/W/URN_NBN_SI_doc-W0WOVSQZ_001.pdf</relation><relation>documents/doc/W/URN_NBN_SI_doc-W0WOVSQZ_001.txt</relation><format format_type="issue">2</format><format format_type="volume">61</format><format format_type="type">article</format><format format_type="extent">str. 66-72</format><identifier identifier_type="ISSN">0014-8229</identifier><identifier identifier_type="COBISSID">2784625</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-W0WOVSQZ</identifier><language>slv</language><publisher>Slovensko farmacevtsko društvo</publisher><source>Farmacevtski vestnik</source><rights>InC</rights><subject language_type_id="slv">antidepresivi</subject><subject language_type_id="slv">depresija</subject><subject language_type_id="slv">farmakoterapija</subject><subject language_type_id="slv">mehanizem delovanja</subject><title>Drugs for the treatment of depression</title><title>Pregled zdravilnih učinkovin za zdravljenje depresije</title></Record>